Jump to: Page Content, Site Navigation, Site Search,
Correspondence to:
Edited by Bob Phillips
| The first 150 words of the full text of this article appear below. |
Archimedes seeks to assist practising clinicians by providing "evidence based" answers to common questions that are not at the forefront of research but are at the core of practice (format adapted from BestBETS published in the Emergency Medicine Journal). A full description of the format is available online at http://adc.bmj.com/ifora/archimedes.dtl.
Readers wishing to submit their own questions—with best evidence answers—are encouraged to review those already proposed at www.bestbets.org. If your question still hasn’t been answered, feel free to submit your summary according to the instructions for authors at http://adc.bmj.com/ifora/archimedes.dtl.
It’s uncommon for us, as paediatricians, to be asked about how cost effective our treatments are. Glancing at the media shows health stories about the new wonder drugs in adult cancer, or in Alzheimer’s disease, and how they are being restricted by a heartless and miserly health system. Where do these statements about "cost effectiveness" come from?
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics
EISSN 1743-0593
ISSN 1743-0585
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health. All rights reserved.
